The super elongation complex drives transcriptional addiction in MYCN -amplified neuroblastoma
Science Advances · 31.03.2023 · 9 (13)
DOI: 10.1126/sciadv.adf0005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 31.03.2023. Verfasst von Donghai Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Medical Research Institute, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan 430071, China. Hauptthemen laut MEDLINE: Nuclear Proteins, Neuroblastoma. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
MYCN amplification in neuroblastoma leads to aberrant expression of MYCN oncoprotein, which binds active genes promoting transcriptional amplification. Yet, how MYCN coordinates transcription elongation to meet productive transcriptional amplification and which elongation machinery represents MYCN-driven vulnerability remain to be identified. We conducted a targeted screen of transcription elongation factors and identified the super elongation complex (SEC) as a unique vulnerability in MYCN -amplified neuroblastomas. MYCN directly binds EAF1 and recruits SEC to enhance processive transcription elongation. Depletion of EAF1 or AFF1/AFF4, another core subunit of SEC, leads to a global reduction in transcription elongation and elicits selective apoptosis of MYCN -amplified neuroblastoma cells. A combination screen reveals SEC inhibition synergistically potentiates the therapeutic efficacies of FDA-approved BCL-2 antagonist ABT-199, in part due to suppression of MCL1 expression, both in MYCN -amplified neuroblastoma cells and in patient-derived xenografts. These findings identify disruption of the MYCN-SEC regulatory axis as a promising therapeutic strategy in neuroblastoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Urology, Medical Research Institute, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan 430071, China.
- Frontier Science Center for Immunology and Metabolism, Wuhan University, Wuhan 430071, China.
- Department of Pathophysiology, School of Basic Medical Sciences, Wuhan University, Wuhan 430071, China.
- Department of Immunology, School of Basic Medical Sciences, Wuhan University, Wuhan 430071, China.
- Department of Pediatric Surgery, Children's Hospital of Fudan University and Shanghai Key Laboratory of Birth Defects, Shanghai 201102, China.
- Taikang Center for Life and Medical Sciences, Wuhan University, Wuhan 430071, China.
ORCID-Profile: Donghai Wang, Zhinang Yin, Honghong Wang, Ruijing Xiao, Hudan Liu, Kaiwei Liang, Guoliang Qing
Zitieren
APA
Wang, D., Yin, Z., Wang, H., Wang, L., Li, T., Xiao, R., Xie, T., Han, R., Dong, R., Liu, H., Liang, K., & Qing, G. (2023). The super elongation complex drives transcriptional addiction in MYCN -amplified neuroblastoma. Science Advances, 9(13). https://doi.org/10.1126/sciadv.adf0005
Vancouver
Wang D, Yin Z, Wang H, Wang L, Li T, Xiao R, et al. The super elongation complex drives transcriptional addiction in MYCN -amplified neuroblastoma. Science Advances. 2023;9(13). doi:10.1126/sciadv.adf0005
BibTeX
@article{Wang2023,
author = {Wang, Donghai and Yin, Zhinang and Wang, Honghong and Wang, Liyuan and Li, Tianyu and Xiao, Ruijing and Xie, Ting and Han, Ruyi and Dong, Rui and Liu, Hudan and Liang, Kaiwei and Qing, Guoliang},
title = {The super elongation complex drives transcriptional addiction in MYCN -amplified neuroblastoma},
journal = {Science Advances},
year = {2023},
volume = {9},
number = {13},
doi = {10.1126/sciadv.adf0005}
}
EUVIMED